New imaging study aims to improve detection of prostate cancer recurrence

NCT ID NCT07184970

Recruiting now Knowledge-focused Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 30 times

Summary

This study looks at whether a special type of scan (PSMA PET/MRI) is better than a standard MRI at finding prostate cancer that has come back one year after a focused ultrasound treatment called HIFU. About 60 men who have already had HIFU for their prostate cancer will get both scans and a biopsy to check for any remaining cancer. The goal is to see if the newer scan can spot problems that the standard MRI might miss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

NYU Langone Health
RECRUITING

New York, New York, 10016, United States

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER